Last edition
News about "Fixed-Dose Triple Therapy for COPD"
Glenmark Launches New Fixed-Dose Triple Therapy for COPD
The treatment combines three medications—an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA)—into a single inhaler, aiming to simplify therapy and improve patient adherence.
Fixed-Dose Triple Therapy For COPD | 26/11/2025 | By Darshana | 132
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members